AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / PHARMACEUTICAL PREPARATIONS
Kailera Therapeutics, Inc. Common Stock
XNAS · usd
SIC 2834 · PHARMACEUTICAL PREPARATIONS
FIGI BBG01Q3NQQK9
12.85▼ 0.42 (-3.17%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
—
Trailing P/E
—
Price / Sales
—
EV / Revenue
—
EV / EBITDA
—
Financial Highlights
Revenue (TTM)
—
Net Income (TTM)
—
EBITDA
—
Diluted EPS (TTM)
—
EBITDA Margin
—
Net Debt
—
Trading Information
Previous Close
13.27
Day's Range
12.46 – 13.18
52-Week Range
9.76 – 28.23
Volume
1.6M
Avg Volume
1.4M
Share Statistics
Shares Outstanding
Employees
—
Exchange
XNAS
Listed
2026-04-17
Share count as of August 6, 2026

Kailera Therapeutics, Inc. Common Stock (KLRA) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about Kailera Therapeutics, Inc. Common Stock (KLRA)
What is Kailera Therapeutics, Inc. Common Stock's Market Cap?
Kailera Therapeutics, Inc. Common Stock's Market Cap is $1.7B, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · KLRAAs-filed SEC (XBRL) data
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Jun 30, 2025Mar 31, 2025
Operating expenses
Research and development
General and administrative
Total operating expenses
Loss from operations
Interest income
Other income (expense), net—
Total other income
Net loss
Net loss per share attributable to common stockholders - basic
Net loss per share attributable to common stockholders - diluted